Dr. Adina Luba Kalet Selected as NBME’s 2023 John P. Hubbard Award Recipient PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- Adina Luba Kalet, MD, MPH, FACP, FAACH, was selected as the recipient of NBME’s 2023 John P. Hubbard Award in recognition of her extensive...

Lexington Announces First Multicenter Clinical Study Site VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...

Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M - Trial supports Actinium’s strategic expansion of its CD33 program into novel combinations that can lead to increased use of bone marrow transplants and expand the addressable patient population for...